Results of WRAP Offer
WRAP retail offer oversubscribed; company raises £3.34m total including £150k from retail offer.
- Gross proceeds raised £3.34 million
- Retail offer proceeds £150,000
- Subscription shares issued 22,807,143
- Retail offer shares issued 1,071,422
- Total ordinary shares post-admission 163,604,747
Select text to share a quote on X · sign in to keep highlights & notes in your SAR notes
Sareum Holdings PLC (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, is pleased to confirm, further to the announcements made on 26 October 2026, the result of its Subscription. The WRAP retail offer was oversubscribed and closed early, demonstrating strong support from the Company's retail shareholder base. As a result, in accordance with the terms of the WRAP Retail Offer, the Company has decided to increase the size of the offer to partially accommodate some of this excess demand.
The Company announces that it has raised aggregate gross proceeds of approximately £150,000 pursuant to the Retail Offer, alongside the previously announced Subscription. Accordingly, the Company will issue a total of 1,071,422 new Ordinary Shares at the Issue Price pursuant to the Retail Offer.
In total, the Subscription and the Retail Offer have raised gross proceeds of approximately £3.34 million for the Company, via the Subscription of 22,807,143 Subscription Shares and the 1,071,422 Retail Offer Shares.
Admission and Total Voting Rights
Applications have been made for the Subscription Shares and the Retail Offer Shares to be admitted to trading on AIM ("Admission"). Admission is expected to become effective at 8:00 a.m. on or around 29 October 2026.
Upon Admission, the Company's issued ordinary share capital will consist of 163,604,747 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, from Admission the total number of Ordinary Shares and voting rights in the Company will be 163,604,747 . With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The new Ordinary Shares to be issued pursuant to the Retail Offer will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the new Ordinary Shares to be issued pursuant to the Subscription and the Company's existing Ordinary Shares.
Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released at 7:01 a.m. GMT on 26 October 2026.
The Company's LEI is 213800PKERN2DY8FFM72.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.